Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peptidomimetic inhibitors of TMPRSS2 block SARS-CoV-2 infection in cell culture
Lukas Wettstein, Philip Maximilian Knaff, Christian Kersten, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 15

Showing 15 citing articles:

S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review
Reza Nejat, Maziar Fayaz Torshizi, David J. Najafi
Vaccines (2023) Vol. 11, Iss. 2, pp. 204-204
Open Access | Times Cited: 15
Development of ketobenzothiazole-based peptidomimetic TMPRSS13 inhibitors with low nanomolar potency
Alexandre Joushomme, Antoine Désilets, William Champagne, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2025) Vol. 40, Iss. 1
Open Access
Optimizing the Pharmacokinetics and Selectivity of TMPRSS2 Inhibitors
Sára Ferková, Matthieu Lepage, Antoine Désilets, et al.
European Journal of Medicinal Chemistry (2025), pp. 117579-117579
Closed Access
From N-0385 to N-0920: Unveiling a Host-Directed Protease Inhibitor with Picomolar Antiviral Efficacy against Prevalent SARS-CoV-2 Variants
Gabriel Lemieux, Jimena Pérez‐Vargas, Antoine Désilets, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Quercetin and taxifolin inhibits TMPRSS2 activity and its interaction with EGFR in paclitaxel‐resistant breast cancer cells: An in silico and in vitro study
Durga Bhavani Kundrapu, Krishna Chaitanya Amajala, Kothapalli Manaswi, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 2
Open Access | Times Cited: 4
SARS-CoV-2 Spike-Mediated Entry and Its Regulation by Host Innate Immunity
Yu Shi, Huina Hu, Qiangyun Ai, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 639-639
Open Access | Times Cited: 9
Ligand-Based Design of Selective Peptidomimetic uPA and TMPRSS2 Inhibitors with Arg Bioisosteres
Patrick Müller, Collin Zimmer, Ariane F. Frey, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1375-1375
Open Access | Times Cited: 3
Omicsynin B4 potently blocks coronavirus infection by inhibiting host proteases cathepsin L and TMPRSS2
Yihua Li, Kun Wang, Hongmin Sun, et al.
Antiviral Research (2023) Vol. 214, pp. 105606-105606
Open Access | Times Cited: 8
Optimization of Ketobenzothiazole‐Based Type II Transmembrane Serine Protease Inhibitors to Block H1N1 Influenza Virus Replication
Éloïc Colombo, Antoine Désilets, Malihe Hassanzadeh, et al.
ChemMedChem (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 8
Recent Advances in Enzyme Inhibition: A Pharmacological Review
Kuldeep Singh, Bharat Bhushan, Nidhi Mittal, et al.
Current Enzyme Inhibition (2023) Vol. 20, Iss. 1, pp. 2-19
Closed Access | Times Cited: 5
Up, up, down, down: the structural biology of the SARS-CoV-2 spike protein and how it cheats the immune system
Sabrina Stäb, Nicholas M. Pearce, Dale E. Tronrud, et al.
Crystallography Reviews (2024), pp. 1-44
Open Access | Times Cited: 1
Current Views About the Link between SARS-CoV-2 and the Liver: Friends or Foe?
Roberto Lovero, Ioannis Alexandros Charitos, Skënder Topi, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2023) Vol. 24, Iss. 6, pp. 642-650
Closed Access | Times Cited: 3
Structural basis of TMPRSS11D specificity and autocleavage activation
Bryan J. Fraser, Ryan P. Wilson, Olzhas Ilyassov, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
S protein, ACE2 and Host Cell Proteases in SARS-CoV2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword?
Reza Nejat, Maziar Fayaz Torshizi, David J. Najafi
(2022)
Open Access | Times Cited: 1
Bacterial Proteases as Potentially Exploitable Modulators of SARS-CoV-2 Infection: Logic from the Literature, Informatics, and Inspiration from the Dog
Gerald H. Lushington, Annika Linde, Tonatiuh Melgarejo
BioTech (2023) Vol. 12, Iss. 4, pp. 61-61
Open Access
A Review of Remdesivir: As a Lifesaver in the Pandemic of SARS-CoV-2
Aman Patel, Shivendra Kumar, Mohit Saxena
International Journal of Research and Review (2022) Vol. 9, Iss. 11, pp. 538-548
Open Access
Page 1

Scroll to top